journal article·2014-03

Prevention of peritoneal adhesions using polymeric rheological blends

Todd Hoare, Yoon Yeo, Evangelia Bellas, Joost P. Bruggeman, Daniel S. Kohane

Acta Biomaterialia· Volume 10· Issue 3
Publisher page

Abstract

The effectiveness of rheological blends of high molecular weight hyaluronic acid (HA) and low molecular weight hydroxypropyl methylcellulose (HPMC) in the prevention of peritoneal adhesions post-surgery is demonstrated. The physical mixture of the two carbohydrates increased the dwell time in the peritoneum while significantly improving the injectability of the polymer compared with HA alone. HA-HPMC treatment decreased the total adhesion area by ∼ 70% relative to a saline control or no treatment in a repeated cecal injury model in the rabbit. No significant cytotoxicity and minimal inflammation were associated with the blend. Furthermore, no chemical or physical processing was required prior to their use beyond simple mixing.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Intestinal and Peritoneal Adhesions · Hernia repair and management · Surgical Sutures and Adhesives

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (60)

Show source-provided references
1. Peritoneal adhesions and their relation to abdominal surgery. A postmortem study10.1016/S0002-9610(73)80123-0 ↗
2. diZerega GS. Peritoneum, peritoneal healing, and adhesion formation. In: diZerega GS (ed.), Peritoneal Surgery. New York: Springer, 2000, pp. 3–37.10.1007/978-1-4612-1194-5_1 ↗
3. Peritoneal healing and adhesion formation/reformation10.1093/humupd/7.6.556 ↗
4. Impact of previous surgery on time taken for incision and division of adhesions during laparotomy10.1007/BF02237441 ↗
5. Assessment of effectiveness of different doses of methylprednisolone on intraabdominal adhesion prevention
6. Peritoneal fluid concentrations of matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1, and transforming growth factor-beta in women with pelvic adhesions10.1016/S0015-0282(03)00079-7 ↗
7. Peritoneal lavage fluid protease levels after in-vivo administration of tolmetin in hyaluronic acid10.1006/jsre.1993.1168 ↗
8. The preventive effect of rofecoxib in postoperative intraperitoneal adhesions10.1080/00015458.2003.11978403 ↗
9. Inhibition of intra-abdominal adhesion formation with the angiogenesis inhibitor sunitinib10.1016/j.jss.2007.10.010 ↗
10. Effect of bevacizumab on postoperative adhesion formation in a rat uterine horn adhesion model and the correlation with vascular endothelial growth factor and Ki-67 immunopositivity10.1016/j.fertnstert.2011.02.005 ↗
11. The ability of recombinant tissue plasminogen activator to inhibit post-radical pelvic surgery adhesions in the dog model10.1016/S0002-9378(12)90796-6 ↗
12. Crosslinked hyaluronan hydrogels containing mitomycin C reduce postoperative abdominal adhesions10.1016/j.fertnstert.2004.09.038 ↗
13. Prevention of peritoneal adhesions by intraperitoneal administration of vitamin E: an experimental study in rats10.1007/s10350-004-0741-6 ↗
14. Targeting of drugs and nanoparticles to tumors10.1083/jcb.200910104 ↗
15. Ligand-targeted therapeutics in anticancer therapy10.1038/nrc903 ↗
16. Postoperative adhesion after uterine horn surgery in the rat, with the use of Tc710.1016/0028-2243(93)90053-F ↗
17. Prevention of adhesions by high-molecular-weight dextran in rats – reevaluation in 9 experiments
18. Icodextrin and Seprafilm((R)) do not interfere with colonic anastomosis in rats10.1159/000104416 ↗
19. Peritoneal application of chitosan and UV-cross-linkable chitosan10.1002/jbm.a.30740 ↗
20. Prevention of experimental postoperative peritoneal adhesions by N,O-carboxymethyl chitosan10.1016/S0039-6060(96)80096-1 ↗
21. Efficacy of thermosensitive hydroxybutyl chitosan in prevention of post-operative abdominal adhesions in a rat model
22. Evaluation of sodium carboxymethylcellulose for prevention of experimentally induced abdominal adhesions in ponies10.2460/ajvr.1991.52.01.88 ↗
23. Influence of polyethylene glycol 4000 and dextran 70 on adhesion formation in rats10.1006/jsre.1996.4973 ↗
24. Optimization of photopolymerized bioerodible hydrogel properties for adhesion prevention10.1002/jbm.820280710 ↗
25. Preventing postoperative intraperitoneal adhesion formation with Polyactive(Tm), a degradable copolymer acting as a barrier10.1007/BF00121246 ↗
26. Biodegradable and thermoreversible PCLA–PEG–PCLA hydrogel as a barrier for prevention of post-operative adhesion10.1016/j.biomaterials.2011.03.046 ↗
27. Alginate film as a novel post-surgical tissue adhesion barrier10.1163/156856209X435835 ↗
28. The role of Seprafilm(TM) bioresorbable membrane in adhesion prevention
29. Prevention of postsurgical adhesions with an autocrosslinked hyaluronan derivative gel10.1006/jsre.2001.6248 ↗
30. Cross-linked hyaluronate hydrogel prevents adhesion formation and reformation in mouse uterine horn model10.1093/humrep/16.2.353 ↗
31. Hyaluronic acid as a surgical aid in the prevention of adhesions
32. Hydrogel systems for barriers and local drug delivery in the control of wound healing10.1016/0168-3659(95)00162-X ↗
33. Prevention of postoperative adhesions in the rat by in-situ photopolymerization of bioresorbable hydrogel barriers
34. Efficacy of an injectable thermosensitive gel on postoperative adhesion in rat model10.4174/jkss.2010.79.4.239 ↗
35. Prevention of post-surgical abdominal adhesions by a novel biodegradable thermosensitive PECE hydrogel
36. In situ cross-linkable hyaluronic acid hydrogels prevent post-operative abdominal adhesions in a rabbit model10.1016/j.biomaterials.2006.04.043 ↗
37. Prevention of peritoneal adhesions with an in situ cross-linkable hyaluronan hydrogel delivering budesonide10.1016/j.jconrel.2007.04.016 ↗
38. Peritoneal adhesion prevention with an in situ cross-linkable hyaluronan gel containing tissue-type plasminogen activator in a rabbit repeated-injury model10.1016/j.biomaterials.2007.04.033 ↗
39. Novel macromolecular crosslinking hydrogel to reduce intra-abdominal adhesions10.1016/j.jss.2008.09.035 ↗
40. Prevention of postoperative pericardial adhesions with a hyaluronic-acid coating solution – experimental safety and efficacy studies10.1016/S0022-5223(12)70149-6 ↗
41. Reduction of adhesion formation with cross-linked hyaluronic acid after peritoneal surgery in rats10.1016/S0015-0282(99)00368-4 ↗
42. The prevention of peritoneal adhesions by in situ cross-linking hydrogels of hyaluronic acid and cellulose derivatives10.1016/j.biomaterials.2006.10.021 ↗
43. Dextran-based in situ cross-linked injectable hydrogels to prevent peritoneal adhesions10.1016/j.biomaterials.2007.04.017 ↗
44. Anti-inflammatory function of an in situ cross-linkable conjugate hydrogel of hyaluronic acid and dexamethasone10.1016/j.biomaterials.2006.12.012 ↗
45. Lapasin · 1995
46. Novel polysaccharides-based viscoelastic formulations for ophthalmic surgery: rheological characterization10.1016/j.biomaterials.2006.05.036 ↗
47. Fast-gelling injectable blend of hyaluronan and methylcellulose for intrathecal, localized delivery to the injured spinal cord10.1016/j.biomaterials.2005.11.015 ↗
48. In vitro sustained release of bioactive anti-NogoA, a molecule in clinical development for treatment of spinal cord injury10.1016/j.ijpharm.2012.01.035 ↗
49. A new paradigm for local and sustained release of therapeutic molecules to the injured spinal cord for neuroprotection and tissue repair10.1089/ten.tea.2007.0349 ↗
50. A hydrogel-based stem cell delivery system to treat retinal degenerative diseases10.1016/j.biomaterials.2009.12.004 ↗
51. Rheological blends for drug delivery. I. Characterization in vitro10.1002/jbm.a.32392 ↗
52. Rheological blends for drug delivery. II. Prolongation of nerve blockade, biocompatibility, and in vitro-in vivo correlations10.1002/jbm.a.32420 ↗
53. Prevention of tissue injury and postsurgical adhesions by precoating tissues with hyaluronic acid solutions10.1006/jsre.1995.1218 ↗
54. Biodegradation of hyaluronic acid derivatives by hyaluronidase10.1016/0142-9612(94)90248-8 ↗
55. Concentration and turnover of intraperitoneal hyaluronan during inflammation10.1007/BF00918972 ↗
56. The role of hyaluronic acid in wound healing: assessment of clinical evidence10.2165/00128071-200506060-00006 ↗
57. In situ cross-linkable hyaluronan hydrogels containing polymeric nanoparticles for preventing postsurgical adhesions10.1097/01.sla.0000251519.49405.55 ↗
58. Fewer intraperitoneal adhesions with use of hyaluronic acid-carboxymethylcellulose membrane—a randomized clinical trial10.1097/00000658-200202000-00006 ↗
59. Animal adhesion models: design, variables, and relevance
60. Does povidone-iodine liposome hydrogel influence postoperative intraabdominal adhesions?10.1080/00015458.2006.11679955 ↗